SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

79,310.01 0.00
( 0.00%)

Global Indices

Nasdaq

51,872.69 -1,504.43
(-2.82%)

Dow Jones

7,442.16 -267.46
(-3.47%)

Hang Seng

60,935.13 -1,253.50
(-2.02%)

Nikkei 225

10,776.27 -52.94
(-0.49%)

Forex

USD-INR

94.73 -0.07
(-0.07%)

EUR-INR

105.99 -0.12
(-0.11%)

GBP-INR

127.06 -0.04
(-0.03%)

JPY-INR

0.60 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

36.4616629

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

44.18

14213.48

EPS(TTM)

Face Value()

Div & Yield %

7.1

0.29

Back

Osiajee Texfab consolidated net profit declines 15.00% in the June 2026 quarter

Aug 14,2026

Net profit of Osiajee Texfab declined 15.00% to Rs 0.34 crore in the quarter ended June 2026 as against Rs 0.40 crore during the previous quarter ended June 2025. Sales declined 10.00% to Rs 0.72 crore in the quarter ended June 2026 as against Rs 0.80 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	0.72	0.80	-10
OPM %	68.06	46.25	-
PBDT	0.34	0.40	-15
PBT	0.34	0.40	-15
NP	0.34	0.40	-15

79,310.01 0.00 ( 0.00%)

51,872.69 -1,504.43 (-2.82%)

7,442.16 -267.46 (-3.47%)

60,935.13 -1,253.50 (-2.02%)

10,776.27 -52.94 (-0.49%)

94.73 -0.07 (-0.07%)

105.99 -0.12 (-0.11%)

127.06 -0.04 (-0.03%)

0.60 0.00 (-0.31%)